Ipamorelin is a pentapeptide studied in experimental and preclinical models for its selective interaction with the growth hormone secretagogue receptor (GHS-R1a). Research has explored its influence on growth hormone signaling pathways, with interest in its receptor specificity and minimal activity at other endocrine receptors when examined under controlled laboratory conditions.
